US20070021493A1
(en)
|
1999-09-16 |
2007-01-25 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
US6545004B1
(en)
*
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
US7671200B2
(en)
*
|
1999-10-27 |
2010-03-02 |
Cytokinetics, Inc. |
Quinazolinone KSP inhibitors
|
US7230000B1
(en)
|
1999-10-27 |
2007-06-12 |
Cytokinetics, Incorporated |
Methods and compositions utilizing quinazolinones
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
US8852937B2
(en)
|
2000-03-30 |
2014-10-07 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
EA007538B1
(ru)
|
2000-12-11 |
2006-10-27 |
Туларик Инк. |
Антагонисты cxcr3
|
US6469002B1
(en)
*
|
2001-04-19 |
2002-10-22 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
US6794379B2
(en)
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
WO2003018549A2
(en)
*
|
2001-08-30 |
2003-03-06 |
Chemocentryx, Inc. |
Bicyclic compounds as inhibitors of chemokine binding to us28
|
ATE469648T1
(de)
|
2001-09-05 |
2010-06-15 |
Minerva Biotechnologies Corp |
Zusammensetzungen und deren verwendung zur behandlung von krebs
|
US6753428B2
(en)
*
|
2001-11-20 |
2004-06-22 |
Cytokinetics, Inc. |
Process for the racemization of chiral quinazolinones
|
AU2003213092A1
(en)
*
|
2002-02-15 |
2003-09-09 |
Smithkline Beecham Corporation |
Syntheses of quinazolinones
|
US20080070864A1
(en)
|
2002-03-07 |
2008-03-20 |
X-Ceptor Therapeutics, Inc. |
Quinazolinone Modulators Of Nuclear Receptors
|
US7381730B2
(en)
*
|
2002-03-15 |
2008-06-03 |
Bristol-Myers Squibb Company |
3-arylquinazoline derivatives as selective estrogen receptor beta modulators
|
AU2003236354A1
(en)
*
|
2002-04-03 |
2003-10-13 |
Sumitomo Pharmaceuticals Co., Ltd. |
Novel blood sugar controller and method of screening the same
|
WO2003084544A2
(en)
*
|
2002-04-04 |
2003-10-16 |
Cv Therapeutics, Inc. |
Compounds dor increasing abca-1 expression useful for treating coronary artery disease and atherosclerosis
|
US20030225288A1
(en)
*
|
2002-04-12 |
2003-12-04 |
Millennium Pharmaceuticals, Inc. |
Imidazolidine compounds
|
BR0309278A
(pt)
*
|
2002-04-17 |
2005-04-26 |
Cytokinetics Inc |
Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
|
CA2485148A1
(en)
*
|
2002-05-09 |
2003-11-20 |
Cytokinetics, Inc. |
Pyrimidinone compounds, compositions and methods
|
AU2003270015A1
(en)
*
|
2002-05-09 |
2003-12-02 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
AU2003265242A1
(en)
*
|
2002-05-23 |
2003-12-22 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
EP2399903A1
(en)
*
|
2002-05-24 |
2011-12-28 |
Millennium Pharmaceuticals, Inc. |
Ccr9 inhibitors and methods of use thereof
|
EP1556357A4
(en)
*
|
2002-06-14 |
2006-09-13 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
US6949538B2
(en)
|
2002-07-17 |
2005-09-27 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
AU2003256805A1
(en)
*
|
2002-07-23 |
2004-02-09 |
Cytokinetics, Inc. |
Compounds compositions and methods
|
EP1539180A4
(en)
*
|
2002-08-21 |
2006-08-30 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
WO2004024086A2
(en)
*
|
2002-09-13 |
2004-03-25 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
AU2003277079A1
(en)
*
|
2002-09-30 |
2004-05-04 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
MXPA05003607A
(es)
*
|
2002-10-04 |
2005-11-17 |
Prana Biotechnology Ltd |
Compuestos neurologicamente activos.
|
EP1608317B1
(en)
*
|
2003-03-25 |
2012-09-26 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
WO2004092123A2
(en)
*
|
2003-04-10 |
2004-10-28 |
Microbia, Inc. |
Inhibitors of fungal invasion
|
EP1670456A2
(en)
*
|
2003-10-06 |
2006-06-21 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
US20050197327A1
(en)
*
|
2003-11-03 |
2005-09-08 |
Gustave Bergnes |
Compounds, compositions, and methods
|
US20050148593A1
(en)
*
|
2003-11-07 |
2005-07-07 |
Gustave Bergnes |
Compounds, compositions, and methods
|
US7439254B2
(en)
*
|
2003-12-08 |
2008-10-21 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
JP4452839B2
(ja)
*
|
2004-03-09 |
2010-04-21 |
国立大学法人京都大学 |
Cxcr3阻害剤を含有する医薬組成物
|
DK1737831T3
(da)
|
2004-04-02 |
2013-08-19 |
Prana Biotechnology Ltd |
Neurologisk aktive forbindelser
|
US7375102B2
(en)
*
|
2004-06-28 |
2008-05-20 |
Amgen Sf, Llc |
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
|
US7271271B2
(en)
|
2004-06-28 |
2007-09-18 |
Amgen Sf, Llc |
Imidazolo-related compounds, compositions and methods for their use
|
US7939538B2
(en)
*
|
2004-06-28 |
2011-05-10 |
Amgen Inc. |
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
|
WO2006026597A2
(en)
*
|
2004-08-30 |
2006-03-09 |
Smithkline Beecham Corporation |
Novel compositions and methods of treatment
|
KR101231466B1
(ko)
|
2004-09-13 |
2013-02-07 |
오노 야꾸힝 고교 가부시키가이샤 |
질소 함유 복소환 유도체 및 이들을 유효 성분으로 하는약제
|
CA2582324A1
(en)
*
|
2004-10-01 |
2006-04-13 |
Merck & Co., Inc. |
Compositions and methods for treating ophthalmic diseases
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
JPWO2006129679A1
(ja)
|
2005-05-31 |
2009-01-08 |
小野薬品工業株式会社 |
スピロピペリジン化合物およびその医薬用途
|
US7799795B2
(en)
|
2005-06-27 |
2010-09-21 |
Amgen Inc. |
Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders
|
DE602006018176D1
(en)
*
|
2005-09-26 |
2010-12-23 |
Merck Sharp & Dohme |
N-(4-oxo-3,4-dihydrochinazolin-2-yl)butanamide als androgenrezeptormodulatoren
|
CA2644368A1
(en)
|
2006-03-10 |
2007-09-20 |
Ono Pharmaceutical Co., Ltd. |
Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
|
CA2647391C
(en)
|
2006-04-04 |
2015-12-29 |
The Regents Of The University Of California |
Kinase antagonists
|
DK2012789T3
(da)
|
2006-04-14 |
2013-12-16 |
Prana Biotechnology Ltd |
Fremgangsmåde til behandling af aldersrelateret makulær degeneration (AMD)
|
US20090325992A1
(en)
|
2006-07-31 |
2009-12-31 |
Ono Pharmaceutical Co., Ltd. |
Compound having cyclic group bound thereto through spiro binding and use thereof
|
JP2009545317A
(ja)
*
|
2006-08-01 |
2009-12-24 |
アプライド バイオシステムズ, エルエルシー |
分析物および核酸の検出
|
AU2007303846B2
(en)
*
|
2006-10-04 |
2011-03-10 |
Pfizer Products Inc. |
Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists
|
US8273747B2
(en)
|
2006-11-02 |
2012-09-25 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
WO2008085828A2
(en)
|
2007-01-03 |
2008-07-17 |
The Johns Hopkins University |
Peptide modulators of angiogenesis and use thereof
|
US20110160232A1
(en)
|
2007-10-04 |
2011-06-30 |
Pingda Ren |
Certain chemical entities and therapeutic uses thereof
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
KR101897881B1
(ko)
|
2008-01-04 |
2018-09-12 |
인텔리카인, 엘엘씨 |
특정 화학 물질, 조성물 및 방법
|
WO2009114874A2
(en)
|
2008-03-14 |
2009-09-17 |
Intellikine, Inc. |
Benzothiazole kinase inhibitors and methods of use
|
US8637542B2
(en)
|
2008-03-14 |
2014-01-28 |
Intellikine, Inc. |
Kinase inhibitors and methods of use
|
WO2010006072A2
(en)
|
2008-07-08 |
2010-01-14 |
The Regents Of The University Of California |
Mtor modulators and uses thereof
|
CN102124009B
(zh)
|
2008-07-08 |
2014-07-23 |
因特利凯公司 |
激酶抑制剂及其使用方法
|
US8703778B2
(en)
|
2008-09-26 |
2014-04-22 |
Intellikine Llc |
Heterocyclic kinase inhibitors
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
WO2010129351A1
(en)
|
2009-04-28 |
2010-11-11 |
Schepens Eye Research Institute |
Method to identify and treat age-related macular degeneration
|
JP5789252B2
(ja)
|
2009-05-07 |
2015-10-07 |
インテリカイン, エルエルシー |
複素環式化合物およびその使用
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
EP2571357B1
(en)
|
2010-05-21 |
2016-07-06 |
Infinity Pharmaceuticals, Inc. |
Chemical compounds, compositions and methods for kinase modulation
|
WO2012064973A2
(en)
|
2010-11-10 |
2012-05-18 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8809349B2
(en)
|
2011-01-10 |
2014-08-19 |
Infinity Pharmaceuticals, Inc. |
Processes for preparing isoquinolinones and solid forms of isoquinolinones
|
US9295673B2
(en)
|
2011-02-23 |
2016-03-29 |
Intellikine Llc |
Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
|
JP6027611B2
(ja)
|
2011-07-19 |
2016-11-16 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
複素環式化合物及びその使用
|
CN103930422A
(zh)
|
2011-07-19 |
2014-07-16 |
无限药品股份有限公司 |
杂环化合物及其用途
|
AU2012302197B2
(en)
|
2011-08-29 |
2016-01-07 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US8828998B2
(en)
|
2012-06-25 |
2014-09-09 |
Infinity Pharmaceuticals, Inc. |
Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
|
AU2013323426A1
(en)
|
2012-09-26 |
2015-04-23 |
The Regents Of The University Of California |
Modulation of ire1
|
US9481667B2
(en)
|
2013-03-15 |
2016-11-01 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
JP6466924B2
(ja)
|
2013-10-04 |
2019-02-06 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
複素環式化合物及びその使用
|
US9751888B2
(en)
|
2013-10-04 |
2017-09-05 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
DK3119397T3
(da)
|
2014-03-19 |
2022-03-28 |
Infinity Pharmaceuticals Inc |
Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
|
AR099789A1
(es)
*
|
2014-03-24 |
2016-08-17 |
Actelion Pharmaceuticals Ltd |
Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina
|
WO2015160975A2
(en)
|
2014-04-16 |
2015-10-22 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
KR20180058741A
(ko)
|
2015-09-14 |
2018-06-01 |
인피니티 파마슈티칼스, 인코포레이티드 |
이소퀴놀리논의 고체형, 그의 제조 방법, 이를 포함하는 조성물 및 이를 사용하는 방법
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
US10919914B2
(en)
|
2016-06-08 |
2021-02-16 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
CA3028718A1
(en)
|
2016-06-24 |
2017-12-28 |
Infinity Pharmaceuticals, Inc. |
Combination therapies
|
US20230321063A1
(en)
*
|
2020-08-20 |
2023-10-12 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Compositions and methods to reduce neuroinflammation
|